Related Experiment Video

Updated: May 30, 2026

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
10:06

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

Management of fungal lung disease in the immunocompromised

Anowara Islam1, Christopher H Mody

  • 1Snyder Institute for Infection, Inflammation and Immunity, University of Calgary, Alberta, Canada.

Therapeutic Advances in Respiratory Disease
|August 3, 2011
PubMed

Insights

Pulmonary mycoses are serious fungal infections in immunocompromised patients. Advances in diagnostics and antifungal therapies offer new management strategies for these challenging infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Management

Background:

  • Pulmonary mycoses represent a significant threat to immunocompromised individuals.
  • Increasing numbers of immunocompromised patients have led to a rise in fungal infection prevalence and severity.
  • Diagnosing and managing fungal infections in this population presents unique challenges.

Purpose of the Study:

  • To review common pulmonary fungal infections in immunocompromised patients.
  • To focus on the management strategies for these infections.
  • To highlight recent advances in diagnostics and antifungal therapy.

Main Methods:

  • Literature review of pulmonary mycoses in immunocompromised patients.
  • Analysis of current diagnostic approaches.
  • Evaluation of contemporary antifungal treatment guidelines.

Main Results:

  • Commonly occurring pulmonary fungal infections identified.
  • Challenges in diagnosis and management detailed.
  • Recent advancements in diagnostics and therapy discussed.

Conclusions:

  • Pulmonary mycoses require vigilant management in immunocompromised patients.
  • New diagnostic and therapeutic advances offer improved patient outcomes.
  • Effective management relies on early detection and tailored antifungal strategies.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment